New imaging compound might 'see' Alzheimer's earlier
...compound, developed by UCLA and called FDDNP, also holds promise as a research tool to evaluate new treatments for Alzheimer's. The study was funded in part by the National Institute on Aging (NIA), one of the National Institutes of Health (NIH). FDDNP binds to plaques and tangles, enabling researchers to...Options improving for patients with acromegaly and gigantism, says endocrinology expert
... directs the medical center's Pituitary Center and holds the Helene A. and Philip E. Hixon Endowed Chair in Investigative Medicine. "Despite the improvements, acromegaly remains a very challenging and very complex disease," he said. "If it occurs before the end of puberty, the patients become giants, suff...M. D. Anderson reports first drug activity in T315I-Positive CML, ALL and JAK-2-Positive MPD
...ertex Pharmaceuticals Incorporated. Merck and Co. holds worldwide and commercialization rights to MK-0457. MK-0457 (VX-680) was discovered by Vertex Pharmaceuticals....Consumers neutral on risks, benefits of nano
...UCL and London Business School, where he currently holds academic appointments. "Measuring public sentiment toward nanotechnology lets us both check the pulse of the industry right now, and chart the growth or erosion of public acceptance in the future." The research was based on more than 5,500 survey r...New breast CT scanner rivals mammography
...e beyond the breast. The University of Rochester holds several patents on the Cone Beam system, which was invented by Ruola Ning, Ph.D., professor of Radiology at the University of Rochester Medical Center and founder of the Rochester, N.Y.-based imaging start-up company, Koning Corporation. www.koningc...Researchers develop novel method for treatment of sickle cell disease
...has a high affinity for sickle cell hemoglobin and holds promise for the treatment of sickle cell disease. "Our findings suggest that this anti-sickling agent may lead to new drug treatments and may one day help those suffering with sickle cell disease. This molecule, 5-HMF, is the most promising molecul...Bacteria could make new library of cancer drugs that are too complex to create artificially
...logues of streptorubin B with all the promise that holds for the development of new anti cancer drugs"...Large subset of learning disabled children can be quickly identified by new diagnostic device
...ystems Corp., a Natus company, of Mundelein, Ill., holds an exclusive license from the University for the technology. "The beauty of BioMAP as a diagnostic tool is that it does not require a child to follow directions or perform an assigned task," says Kraus. "Instead, it objectively measures whether a c...New allergy vaccine provides long-lasting hay fever relief after just 6 weeks of shots
...se receiving a placebo. The experimental therapy holds the promise of one day eliminating the need for traditional allergy medicines targeting allergy symptoms, such as nasal steroids and antihistamines, and providing a safer, faster replacement for immunotherapy regimens, which are costly and take years...Experimental ragweed therapy offers allergy sufferers longer relief with fewer shots
...portant research goal." "This innovative research holds great promise for helping people with allergies," says NIAID Director Anthony S. Fauci, M.D. "A short course of immunotherapy that reduces allergic symptoms over an extended period of time will significantly improve the quality of life for many peopl...OHSU researchers demonstrate how white blood cells cannibalize virus-infected cells
...at the Oregon National Primate Research Center and holds a concurrent appointment in the Department of Molecular Microbiology and Immunology in the OHSU School of Medicine. "While we don't fully understand why this happens, one possibility is that the T-cell consumes virus-infected cells to fuel itself i...Gene transfer using mutant form of good cholesterol cuts vascular plaque and inflammation
... of cholesterol from the macrophages." Shah, who holds the Shapell and Webb Family Endowed Chair in Cardiology at Cedars-Sinai, has been studying apo A-I Milano in its various forms for about 13 years. He and his colleagues developed a synthetic version of the protein and conducted animal studies at Ceda...New study finds a positive association between periodontal disease and coronary heart disease
...r millimeters of alveolar bone loss (the bone that holds the teeth in the mouth) from periodontal disease, according to a new study that is printed in the Journal of Periodontology. It was found that participants with coronary heart disease had an increase of periodontal disease indicators, including alve...All intravascular devices pose risk of bloodstream infection to patients, study finds
...g IVD-related bloodstream infections. "Technology holds far more promise for reducing risk than behavioral... modification," Dr. Maki says. "We believe that it holds the greatest promise. In our paper, we point up a number of IVD technologies that have been proven t...Top NIH prize goes to three pioneering Stanford scientists
... would do if you could do anything you wanted - no holds barred, no strings attached. Tell us the most high-risk, high-impact project you can think of, and we're going to enable you to do it,'" he said. What results is "some of the most creative science imaginable." One of this year's winners, Boahen, ass...Two-faced protein can stop metastasis or promote it, researchers say
...otein known to be a key component of the glue that holds cells together also is involved in breaking them a...vities and the outside skin of humans. "E-cadherin holds a human's cells and tissues together," Anastasiadis says. The other cadherins featured in this stud...Study finds safety test results on children's drugs not always reaching physicians
...(FDA) may extend the period of time that a company holds exclusive marketing rights for a drug -- thereby d...n at the Duke Clinical Research Institute who also holds an appointment at the FDA's Office of Pediatric Therapeutics. "Much of pediatric drug use is done 'o...Improved treatment raises medulloblastoma survival rate
...vely. This reduction in radiation and chemotherapy holds promise for lessening the long-term, troublesome side effects on intellectual development of young patients treated for this cancer, Gajjar said. In addition to improving overall five-year survival of average-risk patients to 85 percent, this grou...Liver diagnosis breakthrough with Mayo Clinic MRI development
...this technology -- called MR Elastography (MRE) -- holds great promise for detecting liver fibrosis, a common condition that can lead to incurable cirrhosis if not treated in time. Traditionally, liver fibrosis is usually diagnosed using needle biopsies, which can involve complications and may be inaccurat......s leading authorities on NMR/MRI technology. Pines holds a joint appointment as a chemist with Berkeley Lab...is new MRI technique along with Dmitry Budker, who holds a joint appointment with Berkeley Lab's Nuclear Science Division and UC Berkeley's Physics Departmen...